GLP

News • Pharma

Lilly to Build $6.5 Billion US Pharmaceutical Plant

Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Houston, Texas.

News

Novo Nordisk Invests $1.09 Billion in Brazil

Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.

News

Reaction Biology Buys Germany’s Bioassay

US contract research organization Reaction Biology has acquired German contract laboratory Bioassay Labor für biologische Analytik and its wholly owned subsidiary Peptide Specialty Laboratories (PSL).

Top-Feature

Evonik Industries AG

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Article

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Eli Lilly and Company

Novo Nordisk A/S

GLP

Lilly to Build $6.5 Billion US Pharmaceutical Plant

Novo Nordisk Invests $1.09 Billion in Brazil

Reaction Biology Buys Germany’s Bioassay

Top-Feature

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Event Sponsorship: Next Generation Batteries and Hydrogen

Predictive Simulation in Pharma Production

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Upcoming Virtual Events

Article

The State of the US Specialty Chemicals Industry

Newsletter & e-edition